CAR T cells: Building on the CD19 paradigm-Reference-Cited by-同舟云学术

CAR T cells: Building on the CD19 paradigm

Published:2021-08-02 Issue:9 Volume:51 Page:2151-2163
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Globerson Levin Anat¹,Rivière Isabelle²,Eshhar Zelig¹,Sadelain Michel²

Affiliation:

1. Immunology Lab Tel Aviv Sourasky Medical Center Tel Aviv Israel

2. Center for Cell Engineering Memorial Sloan Kettering Cancer Center New York NY USA

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202049064

Reference163 articles.

1. CAR therapy: the CD19 paradigm

2. CD19‐Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B‐cell acute lymphoblastic leukemia;Davila M. L.;Clin Adv Hematol Oncol,2016

3. Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective

4. Chimeric Antigen Receptor Therapy

5. The T-body approach: potential for cancer immunotherapy

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma;2024-07-02

2. Greffe de cellules souches hématopoïétiques et thérapies cellulaires dans les maladies auto-immunes;Perfectionnement en Pédiatrie;2024-06

3. Current progress in chimeric antigen receptor T‐cell therapy for malignant tumors;MedComm – Future Medicine;2024-05-13

4. Senolytic CAR T cells reverse aging-associated defects in intestinal regeneration and fitness;2024-03-22

5. Preclinical Evaluation of Novel Folate Receptor 1-Directed CAR T Cells for Ovarian Cancer;Cancers;2024-01-12